Panagora Asset Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,095
Closed -$245K 1504
2022
Q1
$245K Buy
2,095
+53
+3% +$8.77K ﹤0.01% 1408
2021
Q4
$530K Hold
2,042
﹤0.01% 1196
2021
Q3
$557K Buy
2,042
+927
+83% +$267K ﹤0.01% 1270
2021
Q2
$476K Sell
1,115
-38
-3% -$14.5K ﹤0.01% 1338
2021
Q1
$444K Buy
+1,153
New +$519K ﹤0.01% 1390

Other funds holding DRIO

Panagora Asset Management's DRIO Position: Q2 2022 in Review

Panagora Asset Management sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 2,095 shares — an estimated $245K sold.

Panagora Asset Management first reported a position in DRIO in Q1 2021 and held it in 5 quarters. The position peaked at $557K in Q3 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • Panagora Asset Management reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 2,095 DarioHealth shares in Q2 2022, an estimated $245K.
  • Panagora Asset Management first reported a position in DarioHealth in Q1 2021 and held it in 5 quarters.
  • Panagora Asset Management's DarioHealth position peaked at $557K in Q3 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.